Utah Medical Products
UTMD
100 hedge funds and large institutions have $162M invested in Utah Medical Products in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 20 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 31
0% more funds holding
Funds holding: 100 → 100 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
0.87% less ownership
Funds ownership: 69.36% → 68.49% (-0.87%)
9% less capital invested
Capital invested by funds: $177M → $162M (-$15.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$3.16M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.46M |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
+$1.37M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.06M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$2.99M |
| 2 |
CYG
Clean Yield Group
Norwich,
Vermont
|
-$2.1M |
| 3 |
QC
Quadrature Capital
London,
United Kingdom
|
-$1.62M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.26M |
| 5 |
BlackRock
New York
|
-$1.19M |
UTMD Hedge Fund Activity: Q2 2024 in Review
100 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2024, worth a combined $162M — down 8.6% from $177M a quarter earlier.
Fund positioning in UTMD was balanced in Q2 2024: 20 funds opened new positions, 20 closed out, 39 added to existing stakes and 31 trimmed.
The largest buyer was Brandes Investment Partners, adding an estimated $3.16M. The largest seller was Franklin Resources, exiting entirely with an estimated $2.99M sold.
- 100 institutional investors held Utah Medical Products (UTMD) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $162M of Utah Medical Products stock for Q2 2024, down 8.6% quarter-over-quarter.
- 20 funds opened new Utah Medical Products positions in Q2 2024 and 20 closed out, a net change of 0 holders.
- The largest Utah Medical Products buyer in Q2 2024 was Brandes Investment Partners, an estimated $3.16M added.
- The largest Utah Medical Products seller in Q2 2024 was Franklin Resources, an estimated $2.99M sold.
Based on aggregated 13F filings for Q2 2024.